Skip to content
10-Q

Quarterly Report

Translate Bio, Inc.

0001193125-20-286833

← back to feed
Filed
Nov 5, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2020 · Nov 2, 2020 74.32M sh
Shares Diluted Q3 2020 · Sep 30, 2020 76.44M sh
Shares Diluted Q3 2020 · Sep 30, 2020 65.19M sh
Shares Diluted Q3 2020 · Sep 30, 2019 51.89M sh
Shares Diluted Q3 2020 · Sep 30, 2019 48.57M sh
Capex Q3 2020 · Sep 30, 2020 $5.43M
Capex Q3 2020 · Sep 30, 2019 $2.24M
Operating Cash Flow Q3 2020 · Sep 30, 2020 $258.29M
Operating Cash Flow Q3 2020 · Sep 30, 2019 −$61.9M
Cash And Equivalents Q3 2020 · Sep 30, 2020 $674.05M
Cash And Equivalents Q3 2020 · Dec 31, 2019 $84.58M
Cash And Equivalents Q3 2020 · Sep 30, 2019 $98.93M
Stockholders Equity Q3 2020 · Sep 30, 2020 $365.67M
Stockholders Equity Q3 2020 · Jun 30, 2020 $271.39M
Stockholders Equity Q3 2020 · Mar 31, 2020 $142.67M
Stockholders Equity Q3 2020 · Dec 31, 2019 $153.54M
Stockholders Equity Q3 2020 · Sep 30, 2019 $181.57M
Stockholders Equity Q3 2020 · Jun 30, 2019 $115.7M
Stockholders Equity Q3 2020 · Mar 31, 2019 $95.11M
Stockholders Equity Q3 2020 · Dec 31, 2018 $125.3M
Current Liabilities Q3 2020 · Sep 30, 2020 $124.02M
Current Liabilities Q3 2020 · Dec 31, 2019 $41.67M
Total Liabilities Q3 2020 · Sep 30, 2020 $542.96M
Total Liabilities Q3 2020 · Dec 31, 2019 $182.67M
Current Assets Q3 2020 · Sep 30, 2020 $710.96M
Current Assets Q3 2020 · Dec 31, 2019 $203.62M
Total Assets Q3 2020 · Sep 30, 2020 $908.63M
Total Assets Q3 2020 · Dec 31, 2019 $336.2M
Eps Diluted Q3 2020 · Sep 30, 2020 $0.23
Eps Diluted Q3 2020 · Sep 30, 2020 −$0.51
Eps Diluted Q3 2020 · Sep 30, 2019 −$0.41
Eps Diluted Q3 2020 · Sep 30, 2019 −$1.69
Eps Basic Q3 2020 · Sep 30, 2020 $0.24
Eps Basic Q3 2020 · Sep 30, 2020 −$0.51
Eps Basic Q3 2020 · Sep 30, 2019 −$0.41
Eps Basic Q3 2020 · Sep 30, 2019 −$1.69
Sga Expense Q3 2020 · Sep 30, 2020 $9.16M
Sga Expense Q3 2020 · Sep 30, 2020 $25.22M
Sga Expense Q3 2020 · Sep 30, 2019 $6.88M
Sga Expense Q3 2020 · Sep 30, 2019 $21.28M
Rd Expense Q3 2020 · Sep 30, 2020 $26.34M
Rd Expense Q3 2020 · Sep 30, 2020 $76.79M
Rd Expense Q3 2020 · Sep 30, 2019 $17.3M
Rd Expense Q3 2020 · Sep 30, 2019 $51.34M
Net Income Q3 2020 · Sep 30, 2020 $17.34M
Net Income Q3 2020 · Sep 30, 2020 −$33.23M
Net Income Q3 2020 · Jun 30, 2020 −$36.29M
Net Income Q3 2020 · Mar 31, 2020 −$14.28M
Net Income Q3 2020 · Sep 30, 2019 −$21.23M
Net Income Q3 2020 · Sep 30, 2019 −$82.26M
Net Income Q3 2020 · Jun 30, 2019 −$27.83M
Net Income Q3 2020 · Mar 31, 2019 −$33.2M
Operating Income Q3 2020 · Sep 30, 2020 $16.75M
Operating Income Q3 2020 · Sep 30, 2020 −$34.67M
Operating Income Q3 2020 · Sep 30, 2019 −$21.64M
Operating Income Q3 2020 · Sep 30, 2019 −$84.03M
Revenue Q3 2020 · Sep 30, 2020 $66.45M
Revenue Q3 2020 · Sep 30, 2020 $87.42M
Revenue Q3 2020 · Sep 30, 2019 $1.27M
Revenue Q3 2020 · Sep 30, 2019 $3.91M
Short Term Investments Q3 2020 · Dec 31, 2019 $104.1M